AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer 
MarketWatch (press release)
ALBANY, NY, May 21, 2012 (GlobeNewswire via COMTEX) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the ...

and more » 

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC? Vascular Stent 
Sacramento Bee
The Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow. "The Epic Stent System demonstrates an excellent ...
Boston Scientific gets FDA nod, launches Epic stent Mass High Tech
Boston Scientific Announces FDA Approval And US Launch Of EPIC Vascular Stent NASDAQ
Boston Scientific's CE Mark and European Launch of Innova Today's Medical Developments

all 37 news articles » 

THE SAGE GROUP LLC Celebrates its 10th Anniversary as the Leading Research and ... 
MarketWatch (press release)
This puts us in the unique position to be the complete 'one-stop' resource for companies seeking information on atherosclerotic lower limb disease," explained Ms. Yost. PAD, also known as peripheral vascular disease (PVD) is characterized by a ...

and more » 

Boston Scientific gets FDA nod for vascular stent 
Boston Business Journal
(NYSE: BSX) won US Food and Drug Administration approval and immediately launched its Epic Vascular Self-Expanding Stent System, which is designed to open blocked arteries in patients with a form of peripheral vascular disease.
Boston Scientific launches Epic ascular stent system in US pharmabiz.com
FDA Approval for BSX Epic Stent Zacks.com

all 12 news articles » 

Boston Scientific Announces CE Mark and European Launch of Innova(TM) Self ... 
MarketWatch (press release)
"This next-generation stent technology is designed to offer physicians improved acute performance and excellent long-term stent durability, intended to improve overall quality of life for patients with peripheral artery disease.
Boston Scientific Innova Has CE Mark Daily Markets

all 32 news articles » 

The Doctors are in: Peripheral arterial disease, a silent but serious health ... 
Florida Times-Union
Peripheral arterial disease, or PAD, is a rather common disease process affecting well over 12 million Americans. But it is a serious disease; even when completely silent and asymptomatic, it carries a risk of death much higher than most cancers.
DMC Cardiovascular Institute participates in Avinger's CONNECT II Global ... MarketWatch (press release)

all 9 news articles » 

THE SAGE GROUP LLC Announces That Mary L. Yost, President, Will Lecture on ... 
MarketWatch (press release)
NCVH is a peripheral intervention conference focusing on PAD (peripheral artery disease) with a special emphasis on critical limb ischemia (CLI). A unique "head-to-toe" meeting, NCVH brings together a multidisciplinary team of health professionals to ...

and more » 

Larry King Cardiac Foundation Partners with Spirit of Women's HeartCaring To ... 
MarketWatch (press release)
This partnership will compliment current partnerships between HeartCaring and The National Heart, Lung, and Blood Institute (NHLBI), The Heart Truth, Vascular Disease Foundation, the Peripheral Arterial Disease (PAD) Coalition, and the Venous Disease ...

and more » 

Colin to walk 1000 miles despite peripheral vascular disease 
Echo
It left him with pains in his back, but a short while later he was also diagnosed with peripheral vascular disease, a blood condition which constricts blood flow to the legs. He added: ?It hurts me a lot to walk, but I can walk, so I don't want to sit ...

and more » 

AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition 
MarketWatch (press release)
ALBANY, NY, May 15, 2012 (GlobeNewswire via COMTEX) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the ...

and more »